SSMXF
Sysmex Corporation
Price Chart
Latest Quote
$11.35
+0.00 (+0.00%)
Current Price
| Previous Close | $11.35 |
| Open | $11.35 |
| Day High | $11.35 |
| Day Low | $11.35 |
| Volume | 300 |
Stock Information
Note: Financial values converted from JPY to USD
| Quarterly Dividend / Yield | $0.25 / 2.23% |
| Shares Outstanding | 602.04M |
| Quarterly Dividend Yield | 2.23% |
| Quarterly Dividend | $0.25 |
| Total Debt | $784.19M |
| Cash Equivalents | $721.40M |
| Revenue | $3.33B |
| Net Income | $251.37M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $6.83B |
| P/E Ratio | 27.68 |
| EPS (TTM) | $0.41 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $17.36B |
| Sales | $3.33B |
| Income | $251.37M |
| Book/sh | $5.07 |
| Cash/sh | $188.75 |
| Employees | 11K |
Financial Ratios
| Quick Ratio | 2.27 |
| Current Ratio | 3.40 |
| Debt/Eq | 25.41 |
| EPS Growth TTM | 90.90% |
Returns & Margins
| ROA | 6.10% |
| ROE | 8.33% |
| Gross Margin | 50.96% |
| Operating Margin | 11.34% |
| Profit Margin | 7.54% |
Ownership
| Insider Ownership | 27.34% |
| Institutional Ownership | 27.69% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.01 |
| P/B | 2.24 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $11.49 |
| SMA50 | $11.62 |
| SMA200 | $9.62 |
| RSI | nan |
| Shares Float | 513.99M |
| Volatility | 0.77 |
Performance History
| Week | +0.00% |
| Month | -5.73% |
| Quarter | +18.87% |
| 6 Months | +36.07% |
| YTD | +17.75% |
| Year | +7.32% |
| 3 Years | -31.93% |
| 5 Years | -71.12% |
| 10 Years | -42.96% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-30 | $11.35 | 0 |
| 2026-10-29 | $11.35 | 0 |
| 2026-10-28 | $11.35 | 0 |
| 2026-10-27 | $11.35 | 0 |
| 2026-10-26 | $11.35 | 0 |
| 2026-10-23 | $11.35 | 0 |
| 2026-10-22 | $11.35 | 0 |
| 2026-10-21 | $11.35 | 0 |
| 2026-10-20 | $11.35 | 0 |
| 2026-10-19 | $11.35 | 0 |
| 2026-10-16 | $11.35 | 0 |
| 2026-10-15 | $11.35 | 0 |
| 2026-10-14 | $11.35 | 0 |
| 2026-10-13 | $11.35 | 0 |
| 2026-10-12 | $11.35 | 0 |
| 2026-10-09 | $11.35 | 1,000 |
| 2026-10-08 | $12.04 | 0 |
| 2026-10-07 | $12.04 | 0 |
| 2026-10-06 | $12.04 | 0 |
| 2026-10-05 | $12.04 | 0 |
| 2026-10-02 | $12.04 | 0 |
| 2026-10-01 | $12.04 | 0 |
| 2026-09-30 | $12.04 | 0 |
| 2026-09-29 | $nan | 0 |
About Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers hematology, a major test routinely included in blood tests; Flow Cytometry (FCM) analyzes cell properties by irradiating individual cells with a laser and measuring the intensity of light scattering and fluorescence; urinalysis test checks for the presence of glucose, proteins, and blood in urine; clinical chemistry; hemostasis; immunochemistry; cancer gene testing; and antimicrobial susceptibility testing. The company also provides Caresphere, an ICT solution, which integrates and analyzes real time various data managed through testing instruments and clinical testing information systems, and supports the efficient operation of clinical laboratories; and involved in the medical robotics business. It serves products and services to medical institutions, clinical laboratories, animal hospitals, and research institutes. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
đ° Latest News
No news articles available at the moment. Check back later for updates on SSMXF.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $236,665,000,000 | $219,013,000,000 | $194,419,000,000 | $173,195,000,000 |
| Cost Of Revenue | $236,665,000,000 | $219,013,000,000 | $194,419,000,000 | $173,195,000,000 |
| Total Revenue | $508,643,000,000 | $461,510,000,000 | $410,502,000,000 | $363,780,000,000 |
| Operating Revenue | $508,643,000,000 | $461,510,000,000 | $410,502,000,000 | $363,780,000,000 |
| Expenses | ||||
| Interest Expense | $3,518,000,000 | $2,386,000,000 | $1,566,000,000 | $909,000,000 |
| Total Expenses | $417,846,000,000 | $380,915,000,000 | $334,452,000,000 | $296,362,000,000 |
| Net Non Operating Interest Income Expense | $-2,440,000,000 | $-1,449,000,000 | $-703,000,000 | $-359,000,000 |
| Interest Expense Non Operating | $3,518,000,000 | $2,386,000,000 | $1,566,000,000 | $909,000,000 |
| Operating Expense | $181,181,000,000 | $161,902,000,000 | $140,033,000,000 | $123,167,000,000 |
| Other Operating Expenses | $948,000,000 | $905,000,000 | $705,000,000 | $3,557,000,000 |
| General And Administrative Expense | $150,848,000,000 | $133,798,000,000 | $112,371,000,000 | $94,235,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $53,669,000,000 | $49,639,000,000 | $45,784,000,000 | $44,092,000,000 |
| Net Interest Income | $-2,440,000,000 | $-1,449,000,000 | $-703,000,000 | $-359,000,000 |
| Interest Income | $1,078,000,000 | $937,000,000 | $863,000,000 | $550,000,000 |
| Normalized Income | $55,839,636,000 | $51,113,070,000 | $47,358,720,000 | $44,092,000,000 |
| Net Income From Continuing And Discontinued Operation | $53,669,000,000 | $49,639,000,000 | $45,784,000,000 | $44,092,000,000 |
| Total Operating Income As Reported | $87,583,000,000 | $78,382,000,000 | $73,679,000,000 | $67,416,000,000 |
| Net Income Common Stockholders | $53,669,000,000 | $49,639,000,000 | $45,784,000,000 | $44,093,000,000 |
| Net Income | $53,669,000,000 | $49,639,000,000 | $45,784,000,000 | $44,092,000,000 |
| Net Income Including Noncontrolling Interests | $53,576,000,000 | $49,774,000,000 | $45,725,000,000 | $44,071,000,000 |
| Net Income Continuous Operations | $53,576,000,000 | $49,774,000,000 | $45,725,000,000 | $44,072,000,000 |
| Pretax Income | $79,221,000,000 | $74,600,000,000 | $68,713,000,000 | $64,346,000,000 |
| Special Income Charges | $-3,211,000,000 | $-2,210,000,000 | $-2,368,000,000 | $0 |
| Interest Income Non Operating | $1,078,000,000 | $937,000,000 | $863,000,000 | $550,000,000 |
| Operating Income | $90,796,000,000 | $80,595,000,000 | $76,049,000,000 | $67,418,000,000 |
| Gross Profit | $271,977,000,000 | $242,497,000,000 | $216,082,000,000 | $190,585,000,000 |
| Per Share | ||||
| Diluted EPS | $86.05 | $79.24 | $72.91 | $70.16 |
| Basic EPS | $86.07 | $79.27 | $72.94 | $70.29 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,040,364,000 | $-735,930,000 | $-793,280,000 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $124,983,000,000 | $115,084,000,000 | $104,454,000,000 | $92,686,000,000 |
| Total Unusual Items | $-3,211,000,000 | $-2,210,000,000 | $-2,368,000,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-3,211,000,000 | $-2,210,000,000 | $-2,368,000,000 | $0 |
| Reconciled Depreciation | $39,033,000,000 | $35,888,000,000 | $31,807,000,000 | $27,431,000,000 |
| EBITDA (Bullshit earnings) | $121,772,000,000 | $112,874,000,000 | $102,086,000,000 | $92,686,000,000 |
| EBIT | $82,739,000,000 | $76,986,000,000 | $70,279,000,000 | $65,255,000,000 |
| Diluted Average Shares | $623,695,526 | $626,438,667 | $627,682,556 | $628,422,000 |
| Basic Average Shares | $623,550,598 | $626,201,590 | $627,682,556 | $627,273,000 |
| Diluted NI Availto Com Stockholders | $53,669,000,000 | $49,639,000,000 | $45,784,000,000 | $44,093,000,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $-1,000,000 |
| Minority Interests | $93,000,000 | $-135,000,000 | $59,000,000 | $21,000,000 |
| Tax Provision | $25,645,000,000 | $24,826,000,000 | $22,988,000,000 | $20,274,000,000 |
| Write Off | $3,211,000,000 | $2,210,000,000 | $2,368,000,000 | $0 |
| Research And Development | $31,455,000,000 | $31,402,000,000 | $31,060,000,000 | $26,784,000,000 |
| Selling General And Administration | $150,848,000,000 | $133,798,000,000 | $112,371,000,000 | $94,235,000,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $357,425,000,000 | $328,038,000,000 | $297,293,000,000 | $278,033,000,000 |
| Total Assets | $665,268,000,000 | $618,920,000,000 | $531,074,000,000 | $483,707,000,000 |
| Total Non Current Assets | $300,447,000,000 | $275,461,000,000 | $235,583,000,000 | $208,614,000,000 |
| Other Non Current Assets | $6,883,000,000 | $4,344,000,000 | $3,847,000,000 | $3,912,000,000 |
| Non Current Deferred Taxes Assets | $17,651,000,000 | $14,018,000,000 | $10,880,000,000 | $8,520,000,000 |
| Investmentin Financial Assets | $12,034,000,000 | $14,034,000,000 | $9,777,000,000 | $9,157,000,000 |
| Goodwill And Other Intangible Assets | $106,351,000,000 | $104,007,000,000 | $90,372,000,000 | $70,270,000,000 |
| Other Intangible Assets | $92,146,000,000 | $86,786,000,000 | $73,530,000,000 | $57,260,000,000 |
| Current Assets | $364,821,000,000 | $343,459,000,000 | $295,491,000,000 | $275,092,000,000 |
| Other Current Assets | $28,533,000,000 | $29,518,000,000 | $24,927,000,000 | $18,731,000,000 |
| Inventory | $81,811,000,000 | $79,123,000,000 | $73,310,000,000 | $61,944,000,000 |
| Taxes Receivable | $1,246,000,000 | $934,000,000 | $600,000,000 | $470,000,000 |
| Accounts Receivable | $163,007,000,000 | $157,067,000,000 | $126,319,000,000 | $118,697,000,000 |
| Cash Cash Equivalents And Short Term Investments | $90,224,000,000 | $76,817,000,000 | $70,335,000,000 | $75,250,000,000 |
| Cash And Cash Equivalents | $89,570,000,000 | $75,507,000,000 | $69,460,000,000 | $73,752,000,000 |
| Debt | ||||
| Total Debt | $64,735,000,000 | $55,339,000,000 | $22,591,000,000 | $22,279,000,000 |
| Long Term Debt And Capital Lease Obligation | $55,485,000,000 | $46,680,000,000 | $15,442,000,000 | $15,840,000,000 |
| Long Term Debt | $32,359,000,000 | $28,600,000,000 | $0 | - |
| Current Debt And Capital Lease Obligation | $9,250,000,000 | $8,659,000,000 | $7,149,000,000 | $6,439,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $200,734,000,000 | $186,023,000,000 | $142,718,000,000 | $134,654,000,000 |
| Total Non Current Liabilities Net Minority Interest | $77,908,000,000 | $67,939,000,000 | $31,616,000,000 | $32,572,000,000 |
| Other Non Current Liabilities | $11,611,000,000 | $10,353,000,000 | $7,062,000,000 | $8,540,000,000 |
| Non Current Deferred Taxes Liabilities | $7,575,000,000 | $7,917,000,000 | $6,450,000,000 | $6,613,000,000 |
| Current Liabilities | $122,826,000,000 | $118,084,000,000 | $111,102,000,000 | $102,082,000,000 |
| Other Current Liabilities | $11,198,000,000 | $10,315,000,000 | $8,352,000,000 | $6,668,000,000 |
| Payables | $44,649,000,000 | $46,078,000,000 | $46,340,000,000 | $44,924,000,000 |
| Total Tax Payable | $12,784,000,000 | $12,476,000,000 | $14,662,000,000 | $12,813,000,000 |
| Accounts Payable | $31,865,000,000 | $33,602,000,000 | $31,678,000,000 | $32,111,000,000 |
| Equity | ||||
| Common Stock Equity | $463,776,000,000 | $432,045,000,000 | $387,665,000,000 | $348,303,000,000 |
| Total Equity Gross Minority Interest | $464,534,000,000 | $432,897,000,000 | $388,356,000,000 | $349,053,000,000 |
| Stockholders Equity | $463,776,000,000 | $432,045,000,000 | $387,665,000,000 | $348,303,000,000 |
| Other Equity Interest | $37,427,000,000 | $42,816,000,000 | $18,925,000,000 | $8,310,000,000 |
| Retained Earnings | $402,820,000,000 | $365,985,000,000 | $334,192,000,000 | $305,710,000,000 |
| Long Term Equity Investment | $339,000,000 | $472,000,000 | $92,000,000 | $986,000,000 |
| Other | ||||
| Treasury Shares Number | $5,873,371 | $5,872,332 | $1,341,000 | $1,341,000 |
| Ordinary Shares Number | $623,599,805 | $623,498,784 | $627,740,976 | $627,631,086 |
| Share Issued | $629,473,176 | $629,371,116 | $629,081,976 | $628,972,086 |
| Tangible Book Value | $357,425,000,000 | $328,038,000,000 | $297,293,000,000 | $278,033,000,000 |
| Invested Capital | $496,135,000,000 | $460,645,000,000 | $387,665,000,000 | $348,303,000,000 |
| Working Capital | $241,995,000,000 | $225,375,000,000 | $184,389,000,000 | $173,010,000,000 |
| Capital Lease Obligations | $32,376,000,000 | $26,739,000,000 | $22,591,000,000 | $22,279,000,000 |
| Total Capitalization | $496,135,000,000 | $460,645,000,000 | $387,665,000,000 | $348,303,000,000 |
| Minority Interest | $758,000,000 | $851,000,000 | $690,000,000 | $750,000,000 |
| Treasury Stock | $12,318,000,000 | $12,315,000,000 | $314,000,000 | $312,000,000 |
| Additional Paid In Capital | $20,960,000,000 | $20,830,000,000 | $20,580,000,000 | $20,483,000,000 |
| Capital Stock | $14,887,000,000 | $14,729,000,000 | $14,282,000,000 | $14,112,000,000 |
| Common Stock | $14,887,000,000 | $14,729,000,000 | $14,282,000,000 | $14,112,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $2,127,000,000 | $2,239,000,000 | $1,959,000,000 | $1,183,000,000 |
| Long Term Capital Lease Obligation | $23,126,000,000 | $18,080,000,000 | $15,442,000,000 | $15,840,000,000 |
| Long Term Provisions | $1,054,000,000 | $674,000,000 | $398,000,000 | $366,000,000 |
| Current Capital Lease Obligation | $9,250,000,000 | $8,659,000,000 | $7,149,000,000 | $6,439,000,000 |
| Current Provisions | $1,164,000,000 | $1,159,000,000 | $1,123,000,000 | $1,234,000,000 |
| Defined Pension Benefit | $0 | $458,000,000 | $614,000,000 | $841,000,000 |
| Available For Sale Securities | $12,034,000,000 | $14,034,000,000 | $9,777,000,000 | $9,157,000,000 |
| Goodwill | $14,205,000,000 | $17,221,000,000 | $16,842,000,000 | $13,010,000,000 |
| Net PPE | $130,211,000,000 | $116,693,000,000 | $102,106,000,000 | $98,525,000,000 |
| Other Short Term Investments | $654,000,000 | $1,310,000,000 | $875,000,000 | $1,498,000,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $38,287,000,000 | $13,714,000,000 | $26,330,000,000 | $26,705,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $88,246,000,000 | $63,905,000,000 | $68,835,000,000 | $58,739,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-49,959,000,000 | $-50,191,000,000 | $-42,505,000,000 | $-32,034,000,000 |
| Investing Cash Flow | $-52,488,000,000 | $-54,970,000,000 | $-51,751,000,000 | $-35,052,000,000 |
| Net Other Investing Changes | $-1,496,000,000 | $-506,000,000 | $-1,510,000,000 | $-2,159,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-2,000,000 | $-12,001,000,000 | $-1,000,000 | - |
| Issuance Of Capital Stock | $248,000,000 | $703,000,000 | $267,000,000 | $1,384,000,000 |
| Financing Cash Flow | $-24,322,000,000 | $-9,013,000,000 | $-24,234,000,000 | $-20,542,000,000 |
| Cash Dividends Paid | $-18,081,000,000 | $-17,579,000,000 | $-16,528,000,000 | $-15,258,000,000 |
| Common Stock Dividend Paid | $-18,081,000,000 | $-17,579,000,000 | $-16,528,000,000 | $-15,258,000,000 |
| Net Common Stock Issuance | $246,000,000 | $-11,298,000,000 | $266,000,000 | $1,384,000,000 |
| Common Stock Issuance | $248,000,000 | $703,000,000 | $267,000,000 | $1,384,000,000 |
| Net Other Financing Charges | - | $-68,000,000 | $-13,000,000 | $-91,000,000 |
| Other | ||||
| Repayment Of Debt | $-626,000,000 | $0 | - | - |
| Issuance Of Debt | $4,700,000,000 | $29,000,000,000 | $0 | - |
| End Cash Position | $89,570,000,000 | $75,507,000,000 | $69,460,000,000 | $73,752,000,000 |
| Beginning Cash Position | $75,507,000,000 | $69,460,000,000 | $73,752,000,000 | $66,467,000,000 |
| Effect Of Exchange Rate Changes | $2,627,000,000 | $6,125,000,000 | $2,858,000,000 | $4,139,000,000 |
| Changes In Cash | $11,436,000,000 | $-78,000,000 | $-7,150,000,000 | $3,145,000,000 |
| Common Stock Payments | $-2,000,000 | $-12,001,000,000 | $-1,000,000 | - |
| Net Issuance Payments Of Debt | $4,074,000,000 | $29,000,000,000 | $0 | - |
| Net Long Term Debt Issuance | $4,074,000,000 | $29,000,000,000 | $0 | - |
| Long Term Debt Payments | $-626,000,000 | $0 | - | - |
| Long Term Debt Issuance | $4,700,000,000 | $29,000,000,000 | $0 | - |
| Net Investment Purchase And Sale | $-1,735,000,000 | $-4,226,000,000 | $-5,089,000,000 | $-1,404,000,000 |
| Sale Of Investment | $3,630,000,000 | $1,260,000,000 | $811,000,000 | $755,000,000 |
| Purchase Of Investment | $-5,365,000,000 | $-5,486,000,000 | $-5,900,000,000 | $-2,159,000,000 |
| Net Business Purchase And Sale | $0 | $-574,000,000 | $-2,984,000,000 | $0 |
| Purchase Of Business | $0 | $-574,000,000 | $-2,984,000,000 | $0 |
| Net Intangibles Purchase And Sale | $-20,733,000,000 | $-24,581,000,000 | $-25,020,000,000 | $-19,266,000,000 |
| Purchase Of Intangibles | $-20,733,000,000 | $-24,581,000,000 | $-25,020,000,000 | $-19,266,000,000 |
| Net PPE Purchase And Sale | $-28,524,000,000 | $-25,083,000,000 | $-17,148,000,000 | $-12,223,000,000 |
| Sale Of PPE | $702,000,000 | $527,000,000 | $337,000,000 | $545,000,000 |
| Purchase Of PPE | $-29,226,000,000 | $-25,610,000,000 | $-17,485,000,000 | $-12,768,000,000 |
| Taxes Refund Paid | $-27,723,000,000 | $-28,974,000,000 | $-24,281,000,000 | $-14,705,000,000 |
| Interest Received Cfo | $654,000,000 | $598,000,000 | $676,000,000 | $298,000,000 |
| Interest Paid Cfo | $-1,853,000,000 | $-1,383,000,000 | $-985,000,000 | $-704,000,000 |
| Change In Working Capital | $-9,545,000,000 | $-18,207,000,000 | $-12,159,000,000 | $-24,138,000,000 |
| Change In Other Current Assets | $346,000,000 | $1,358,000,000 | $2,216,000,000 | $-2,259,000,000 |
| Change In Accrued Expense | $1,113,000,000 | $1,483,000,000 | $747,000,000 | $2,044,000,000 |
| Change In Payable | $1,760,000,000 | $2,141,000,000 | $-601,000,000 | $-1,963,000,000 |
| Change In Prepaid Assets | $706,000,000 | $474,000,000 | $-983,000,000 | $832,000,000 |
| Change In Inventory | $-6,320,000,000 | $-1,676,000,000 | $-10,558,000,000 | $-12,495,000,000 |
| Change In Receivables | $-7,150,000,000 | $-21,987,000,000 | $-2,980,000,000 | $-10,297,000,000 |
| Other Non Cash Items | $2,793,000,000 | $-4,061,000,000 | $-491,000,000 | $402,000,000 |
| Depreciation And Amortization | $39,033,000,000 | $35,888,000,000 | $31,807,000,000 | $27,431,000,000 |
| Depreciation | $39,033,000,000 | $35,888,000,000 | $31,807,000,000 | $27,431,000,000 |
| Gain Loss On Sale Of PPE | $383,000,000 | $381,000,000 | $265,000,000 | $2,245,000,000 |
| Net Income From Continuing Operations | $79,221,000,000 | $74,600,000,000 | $68,713,000,000 | $64,346,000,000 |
| Other Cash Adjustment Outside Changein Cash | - | - | - | $1,000,000 |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-02-02